Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 523

l-leucine

Intended Use: For use as an ingredient in milk and non-milk meal replacement beverages, sports beverages, and vitamin enhanced waters, and meal replacement bars at levels of use intended to provide between 1.5 and 3 g of added L-leucine per serving.
Basis: Scientific Procedures
Notifier: INNOBIO Limited
Notifier Address: No. 49, DDA, Dalian, Liaoning 116600, China
Date of filing: Jun 12, 2014
GRAS Notice (releasable information): GRN 523 (in PDF) (1.6 MB)
Date of closure: Dec 11, 2014
FDA's Letter: FDA has no questions
-
-